Business Wire Feed
Trividia Health Correction for TRUE METRIX Blood Glucose Monitoring Systems
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., a global leader in diabetes management, today provided an important update to the medical device labeling correction it announced on February 6, 2026, for all TRUE METRIX®, TRUE METRIX® more...
E-Scopics Announces New FDA Clearance for Hepatoscope® With Expanded Capabilities in Managing Liver Disease Complications, Advanced Elastography Imaging Features, and Improved Compatibility to Be Presented at DDW 2026
The addition of a dedicated spleen exam workflow with real-time 2D transient elastography imaging, compliance with the ultrasound elastography standard IEC 63412-1, compatibility with macOS-based laptops, and connectivity to EHR systems reinforce Hepatoscope’s positioning as more...
Knoa Pharma Begins Operations as a New, Public Health-Focused Company Dedicated to Supporting Patients and Abating the Opioid Crisis
New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible OperationsSTAMFORD, Conn.--(BUSINESS WIRE)--Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company more...
RestorixHealth Celebrates Hyperbaric Awareness Month
RestorixHealth joins industry leaders to commemorate the history, innovation and healing benefits of hyperbaric medicine.METAIRIE, La.--(BUSINESS WIRE)--#WhereHealingHappens--RestorixHealth, the nation’s premier partner for wound care and hyperbaric center management, is pleased to join the broader hyperbaric more...
Agendia to Present New FLEX Study Data at ASBrS 2026 Confirming the Consistent Performance of MammaPrint + BluePrint Across Diverse Racial Groups in Genomically Basal-Type Breast Cancer
Multivariate analyses reveal that pathologic complete response is associated with transcriptomic differences and chemotherapy type, rather than self-reported raceIRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., a leader in precision oncology for breast cancer, today announced that more...
Cairn Surgical Reports Pivotal Trial Results for Its Breast Cancer Locator System
SEATTLE--(BUSINESS WIRE)--#BCSM--Cairn Surgical, Inc., an innovative medical technology company striving to make breast cancer surgery more precise, announced today the results of its pivotal trial evaluating its investigational Breast Cancer Locator (BCLTM) System. The study more...
Sequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup Accelerator
Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS WIRE)--Sequenex today announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies. MedTech Innovator matches healthcare industry leaders more...
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG
NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of more...
Radiology Partners Appoints Former Gov. Larry Hogan to Board of Directors
Former Maryland governor brings public health, healthcare innovation and executive leadership expertise to esteemed BoardNASHVILLE, Tenn.--(BUSINESS WIRE)--Radiology Partners (RP), the leading technology-enabled radiology practice in the U.S. through its affiliated practices and Mosaic Clinical Technologies™ more...
Relias’ Amy King Honored for Marketing Innovation in the B2B CMO 100
Recognition underscores King’s role in aligning marketing, growth, and customer strategy as Relias expanded its solutionsMORRISVILLE, N.C.--(BUSINESS WIRE)--Relias, the trusted multi-solution workforce enablement partner to 13,000 healthcare organizations and 4.5 million caregivers, today announced that more...
Senior Housing Crunch Fuels Vineyard Park’s Expansion into Seattle’s First Hill
Acquisition and rebrand as Union Grand signal growing demand for urban senior livingMERCER ISLAND, Wash.--(BUSINESS WIRE)--#AgingInPlace--As Seattle faces a tightening supply of senior housing, Vineyard Park Senior Living is moving into the city’s urban core more...
908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the more...
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per month Brief Summary: GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per month Available at more...
Sydnexis to Present New Data from Phase 3 STAR Trial of SYD-101 at ARVO 2026 Annual Meeting
DEL MAR, Calif.--(BUSINESS WIRE)--Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced it will present new data related to a prespecified subgroup analysis more...
Ardent Health to Participate in the Bank of America 2026 Healthcare Conference
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Bank of America 2026 Healthcare Conference on more...
Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program
Annual program honors practices delivering highest quality care and exceptional patient experience in Elevance Health’s affiliated health plans across the countryINDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, along with its affiliated health plans, today announced 45 distinguished medical practices more...
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
– REDEMPLO is the first and only medicine approved for use in the treatment of FCS in Australia, and is authorized for both genetically confirmed and clinically diagnosed adult patients with FCS – People living more...
Ionis to present at upcoming investor conferences
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Bank of America Securities 2026 Health Care Conference on Tuesday, May 12, 2026 2026 more...
Phreesia Sets Release Date for Fiscal First Quarter 2027 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026. Phreesia will issue more...
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health
SAN DIEGO--(BUSINESS WIRE)--Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely more...
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences
FOSTER CITY, Calif.--(BUSINESS WIRE)--#GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Care Conference on Tuesday, May 12 at 2:20 PM Pacific Time more...
Geviti Featured on Health Uncensored with Dr. Drew, Showcasing AI-Powered Preventative Health Platform
National television segment highlights Geviti’s clinically backed AI platform as a new model for interpreting biomarker data and advancing proactive care.PHOENIX--(BUSINESS WIRE)--Geviti Health, a precision health platform focused on preventative care, was recently featured on more...
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
Multi-year global collaboration will leverage Guardant’s tissue and liquid biopsy portfolio to support clinical development and companion diagnostic strategies PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a more...
Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burden Enpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous more...
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
Significant unmet need remains for 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burden Enpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous more...